RxDoctor Payments DataLook up a doctor →

Christopher Recknor

Internal Medicine · Gainesville, GANPI 1306832175

Payments from drug & device makers

$9,165,093in general payments, 2019–2025

Across 1,055 payments — averaging $8687.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$4.7M
  • Eli Lilly$1.2M
  • Regeneron$1.1M
  • Radius Health, Inc.$694K
  • Amgen$549K
  • E.r. Squibb & Sons, L.L.C.$370K
  • plus $539K from 8 others
$11,683in research payments, 2019–2025

Across 14 payments — averaging $834.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$6K
  • Amgen$4K
  • Radius Health, Inc.$2K

General payments by program year

19
20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.235$4,656,940
Eli Lilly21$1,248,058
Regeneron175$1,106,761
Radius Health, Inc.151$694,479
Amgen13$549,280
E.r. Squibb & Sons, L.L.C.2$370,426
Esperion Therapeutics, Inc.442$332,303
Novartis2$118,294
Mallinckrodt Hospital Products Inc.8$81,657
Pfizer1$6,809
Lilly USA, LLC2$31
Mallinckrodt Enterprises LLC1$24
AbbVie1$19
Novo Nordisk1$13

How this compares

$9,165,093 in reported general payments places this provider in the 95th percentile of 3,311 internal medicine providers in Georgia.

See all internal medicine providers in Georgia →

Other internal medicine in Gainesville

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →